As of Wednesday close, HCA Healthcare Inc.’s (NYSE:HCA) stock was down -$2.86, moving down -1.07 percent to $264.90. The average number of shares traded per day over the past five days has been 1,292,900 shares. 2 times new highs have been achieved over the past 5 days, with a -$10.56 fall in that time frame. In the last twenty days, the average volume was 1,140,100, while in the previous 50 days, it was 1,266,332.
Since last month, HCA stock retreated -6.06%. Shares of the company fell to $262.09 on 05/24/23, the lowest level in the past month. A 52-week high of $294.02 was reached on 04/21/23 after having rallying from a 52-week low of $164.47. Since the beginning of this year, HCA’s stock price has risen by 10.39% or $24.94, and marked a new high 15 times. However, the stock has declined by -9.90% since its 52-week high.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
HCA stock investors should be aware that HCA Healthcare Inc. (HCA) stock had its last reported insider trading activity 27 days ago on Apr 28. Cuffe Michael S., the EVP and Chief Clinical Officer of the company, disposed of 12,556 shares for $284.44 on Apr 28. It resulted in a $3,571,396 divestment by the insider. Akdamar Erol R sold 3,500 shares at an average price of $285.00 on Apr 28. The insider now owns 42,484 shares following the transaction. On Apr 24, SVP-Payer Contracting & Align. Torres Kathryn A. sold 4,473 shares at $288.38 apiece. The transaction was valued at $1,289,913.
Right now, HCA Healthcare Inc. (HCA) has a P/E ratio of about 13.28. The stock’s beta is 1.65.
The latest dividend of $0.60 per share was paid out, remained unchanged from last year’s $0.60.
In the three months ended March 30, HCA Healthcare Inc.’s quick ratio stood at 1.00, while its current ratio was 1.20, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 84.40% percent. In the year ended March 30, EBITDA margin amounted to 19.96%, whereas operating margins totaled 15.10%. Based on annual data, HCA earned $50.86 billion in gross profit and brought in $60.23 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 20.50%. Return on equity (ROE) for the past 12 months was -186.30%.
In HCA Healthcare Inc.’s quarter-end financial report for March 30, it reported total debt of $36.48 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. HCA’s revenue rose 4.14% to $15.5 billion during the quarter, while net income inched up to $15.59 billion. While analysts expected HCA Healthcare Inc. to report $3.93 quarterly earnings, the actual figure was $4.93 per share, beating the consensus estimate by 25.40%. During the quarter, the company generated $3.18 billion in EBITDA. The liabilities of HCA Healthcare Inc. were 52.48 billion at the end of its most recent quarter ended March 30, and its total debt was $40.57 billion. The value of shareholders’ equity is $275.19 million.
This quick technical analysis looks at HCA Healthcare Inc.’s (HCA) price momentum. With a historical volatility rate of 22.40%, the RSI 9-day stood at 30.99% on 24 May.
With respect to its five-day moving average, the current HCA Healthcare Inc. price is down by -3.83% percent or -$10.56. At present, HCA shares trade -4.74% below its 20-day simple moving average and +10.20% percent above its 100-day simple moving average. However, the stock is currently trading approximately +5.67% above its SMA50 and +25.34% above its SMA200.
Stochastic coefficient K was 15.81% and Stochastic coefficient D was 33.47%, while ATR was 6.12. Given the Stochastic reading of 11.87% for the 14-day period, the RSI (14) reading has been calculated as 38.08%. As of today, the MACD Oscillator reading stands at -5.21, while the 14-day reading stands at -5.99.
HCA Healthcare Inc. (HCA) has been rated Overweight by analysts. According to 0 brokerage firms, HCA is a sell, and 6 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 2 analysts rate HCA Healthcare Inc. stock as buy, with 17 recommending it as overweight.
With a median target price of $315.00, the current consensus forecast for the stock is $266.00 – $350.00. Based on these forecasts, analysts predict HCA Healthcare Inc. (HCA) will achieve an average price target of $312.36.